Back to results
US 10,201,604 B2Granted
Live attenuated infectious laryngotracheitis virus (ILTV) vaccines and preparation thereof
AssigneeUniversity of Delaware
InventorsJack Gelb, Jr., Brian S. Ladman, Miguel Ruano
Life of this patent
Estimating the term…
Abstract
This disclosure describes a modified live infectious laryngotracheitis virus (ILTV) developed from a strain of ILTV grown at a reduced incubation temperature, vaccines that include the modified live ILTV, methods for producing the live modified ILTV, and methods that include administering the modified ILTV to a subject.
Claims4
A method of producing a live attenuated infectious laryngotracheitis virus (ILTV), the method comprising serially passaging the ILTV in culture for at least 15 serial passages at a temperature of at least 25° C. and no greater than 35° C.
Dependencies are inferred from the claim text.